MannKind Corp. (MNKD)

[TREND1]

MNKD UPDATE

1 REV = 0 It is all about AFREZZA sales.
2 10 fold increase in AFREZZA SCRIPS/WEEK TO BREAK EVEN post 15883
3 AFREZZA (70% HIGHER) still at tier 3 insurance.
4 No FDA approval FOR NEW LABEL for AFREZZA. A1C THE SAME per FDA.
5 NO NEW bonus of 25 million from SNY.
6 NO completion of lung cancer study promised FDA
7 NO second drug being produced. Are other companies cheaper ?
8 NO FDA Approval of AFREZZA for Pediatrics ($5B)
9 TV ADS for AFREZZA post 15871 What if they do not work ?
10 Sanofi REQUIRED TO SEND 90 DAY NOTICE to drop MNKD post 16030
11 $25 million minimum cash required for loan obligations. ($185.4 million).
12 MNKD will get 36.2 million from TASE sale.11/12/15 post 16035
13 SNY can reduce losses by 8% in 2016 by dropping AFREZZA. IMHO.
14 CEO GONE 11/19/15 POST 16122, 16142
15 MannKind: Weekly Data Updates- 11-13-15 Data POST 16163